tiprankstipranks
PDS Biotechnology Corporation (PDSB)
NASDAQ:PDSB

PDS Biotechnology (PDSB) Financial Statements

660 Followers

PDS Biotechnology Financial Overview

PDS Biotechnology's market cap is currently ―. The company's EPS TTM is $-1.374; its P/E ratio is -2.98; PDS Biotechnology is scheduled to report earnings on August 14, 2024, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -9.43M$ -9.72M$ -9.78M$ -11.95M$ -8.69M
EBITDA$ -9.14M$ -9.45M$ -9.57M$ -11.76M$ -8.50M
Net Income Common Stockholders$ -10.60M$ -10.90M$ -10.85M$ -11.53M$ -9.66M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 66.60M$ 56.60M$ 54.30M$ 60.60M$ 65.20M
Total Assets$ 69.01M$ 59.39M$ 57.19M$ 63.73M$ 68.30M
Total Debt$ 24.11M$ 23.85M$ 23.60M$ 23.52M$ 23.51M
Net Debt$ -42.49M$ -32.75M$ -30.70M$ -37.08M$ -41.69M
Total Liabilities$ 31.82M$ 33.26M$ 32.70M$ 31.31M$ 27.44M
Stockholders Equity$ 37.18M$ 26.13M$ 24.48M$ 32.44M$ 41.01M
Cash Flow-
Free Cash Flow$ -9.94M$ -8.46M$ -7.18M$ -4.81M$ -13.19M
Operating Cash Flow$ -9.94M$ -8.46M$ -7.18M$ -4.81M$ -13.19M
Investing Cash Flow-----
Financing Cash Flow$ 20.01M$ 10.77M$ 802.33K$ 196.26K$ 4.58M
Currency in USD

PDS Biotechnology Earnings and Revenue History

PDS Biotechnology Debt to Assets

PDS Biotechnology Cash Flow

PDS Biotechnology Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis